Antera Therapeutics

Harvard Business School

Antera Therapeutics

Clarence Friedman shares the Antera Therapeutics story.

How did you get started at the i-lab?

Antera got started at the i-lab during the Summer VIP. The i-lab was, and continues to be, an incredible home for spurring our company’s innovation and progress.

What’s the #1 resource you use most at the Harvard i-lab? Why is/was it so useful?

Other teams have been a wealth of knowledge and inspiration. Every team, regardless of industry, confronts similar sets of entrepreneurial problems. Whether it’s raising a funding round, vetting third party contractors, or making your first hire, someone in the i-lab has the knowledge to help.

The i-lab does a great job of creating a supportive environment among all the teams, and we’ve been lucky enough to be a part of that.

What’s next for you and your venture?

We are launching our product in February with several clinics in the Boston area. We can’t wait to start protecting infants against peanut allergies. In April, we will begin to develop our multiple allergen product, which will help parents and their pediatricians defend against a range of allergies.

If you had to give another student one piece of advice to get the most out of the i-lab, what would it be?

Get to know the other teams and be comfortable asking for help from everyone. After getting so much from others, Antera is certainly thrilled when we get a chance to pay it forward. Come find us!

Anything we missed?

In the spirit of asking for help, if you know any pediatricians that might like to help us in our fight against allergies, please connect them to us! Or, if you’re just interested in keeping up to date on our progress, please shoot us an email, we would love to connect.